Workflow and Maintenance Characteristics of Five Automated Laboratory Instruments for the Diagnosis of Sexually Transmitted Infections
暂无分享,去创建一个
Sam Ratnam | Dan Jang | Jodi Gilchrist | Marek Smieja | Andre Poirier | Todd Hatchette | Jean-Frederic Flandin | Max Chernesky | S. Ratnam | M. Smieja | M. Chernesky | T. Hatchette | A. Poirier | D. Jang | J. Flandin | J. Gilchrist
[1] E. Portillo,et al. Comparison of Three Assays for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in SurePath Pap Samples and the Role of Pre- and Postcytology Testing , 2012, Journal of Clinical Microbiology.
[2] Alessandra Amendola,et al. Improving clinical laboratory efficiency: a time-motion evaluation of the Abbott m2000 RealTime and Roche COBAS AmpliPrep/COBAS TaqMan PCR systems for the simultaneous quantitation of HIV-1 RNA and HCV RNA , 2011, Clinical chemistry and laboratory medicine.
[3] R. Lillis,et al. Performance of the cobas CT/NG Test Compared to the Aptima AC2 and Viper CTQ/GCQ Assays for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae , 2012, Journal of Clinical Microbiology.
[4] Preeti Pancholi,et al. Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays. , 2011, The Journal of molecular diagnostics : JMD.
[5] D. Whiley,et al. Evaluation of the cobas 4800 CT/NG test for detecting Chlamydia trachomatis and Neisseria gonorrhoeae , 2010, Sexually Transmitted Infections.
[6] J. Cuzick,et al. Comparing the performance of six human papillomavirus tests in a screening population , 2013, British Journal of Cancer.
[7] G. Horsman,et al. Comparison of the BD Viper System With XTR Technology to the Gen-Probe APTIMA COMBO 2 Assay Using the TIGRIS DTS System for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Specimens , 2012, Sexually transmitted diseases.
[8] Robin A. Felder,et al. Process Evaluation of a Fully Automated Molecular Diagnostics System , 2009 .
[9] K. Beavis,et al. Evaluation of automated COBAS AMPLICOR PCR system for detection of several infectious agents and its impact on laboratory management , 1996, Journal of clinical microbiology.
[10] G. Horsman,et al. Evaluation of Three Automated Nucleic Acid Amplification Systems for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in First-Void Urine Specimens , 2008, Journal of Clinical Microbiology.
[11] B. Diedrich,et al. Characteristics of the m2000 Automated Sample Preparation and Multiplex Real-Time PCR System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae , 2007, Journal of Clinical Microbiology.
[12] W. Kortlandt,et al. Standardized comparison of processing capacity and efficiency of five new-generation immunoassay analyzers. , 2000, Clinical chemistry.
[13] J. Mandrekar,et al. Comparison of the Abbott RealTime Human Immunodeficiency Virus Type 1 (HIV-1) Assay to the Cobas AmpliPrep/Cobas TaqMan HIV-1 Test: Workflow, Reliability, and Direct Costs , 2009, Journal of Clinical Microbiology.
[14] S. Ratnam,et al. Head-to-Head Comparison of Second-Generation Nucleic Acid Amplification Tests for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae on Urine Samples from Female Subjects and Self-Collected Vaginal Swabs , 2014, Journal of Clinical Microbiology.
[15] K. Chapin,et al. Comparison of Aptima Trichomonas vaginalis Transcription-Mediated Amplification Assay and BD Affirm VPIII for Detection of T. vaginalis in Symptomatic Women: Performance Parameters and Epidemiological Implications , 2011, Journal of Clinical Microbiology.
[16] J. Welsch,et al. Performance of the Abbott RealTime CT/NG for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae , 2010, Journal of Clinical Microbiology.